Depressive Disorders - Portugal

Portugal

Revenue in the Depressive Disorders market is projected to reach US$158.70m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 1.55%, resulting in a market volume of US$168.80m by 2028.
In global comparison, most revenue will be generated in the United States (US$6,263.00m in 2024).
In relation to total population figures, per person revenues of US$259.30 are generated in 2024.

Key regions: Japan, United Kingdom, China, Europe, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Depressive Disorders market in Portugal is experiencing significant growth due to a combination of customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences: In Portugal, there is a growing awareness and acceptance of mental health issues, including Depressive Disorders. Customers are increasingly seeking professional help and treatment for these conditions, leading to a higher demand for pharmaceutical products and therapies. Additionally, there is a preference for personalized treatment plans that cater to individual needs and preferences, driving the market towards more specialized and targeted solutions.

Trends in the market: One of the key trends in the Depressive Disorders market in Portugal is the shift towards a more holistic approach to treatment. This includes a combination of medication, therapy, and lifestyle changes to address the underlying causes of depression. As a result, there is an increasing demand for complementary therapies such as mindfulness, meditation, and exercise programs. This trend is driven by a growing body of research supporting the effectiveness of these approaches and the desire for a more comprehensive and long-term solution.Another trend in the market is the emergence of digital health solutions. Portugal has seen a rise in the use of mobile applications and online platforms that provide mental health support and resources. These digital tools offer convenience, accessibility, and anonymity, making them particularly appealing to individuals who may be hesitant to seek traditional in-person treatment. The availability of these digital solutions has contributed to the overall growth of the Depressive Disorders market in Portugal.

Local special circumstances: Portugal has a high prevalence of mental health disorders, including Depressive Disorders. This can be attributed to various factors such as economic challenges, social inequalities, and a lack of mental health resources. The government and healthcare system in Portugal have recognized the need to address these issues and have implemented initiatives to improve access to mental health services. This focus on mental health has created a favorable environment for the growth of the Depressive Disorders market.

Underlying macroeconomic factors: The Portuguese economy has been recovering from the financial crisis of 2008, leading to an increase in disposable income and healthcare expenditure. As a result, individuals have more resources to allocate towards mental health treatment, including medication and therapy. Additionally, the aging population in Portugal is also contributing to the growth of the Depressive Disorders market. Older adults are more likely to experience depressive symptoms and are seeking treatment to improve their quality of life.In conclusion, the Depressive Disorders market in Portugal is experiencing growth due to customer preferences for personalized and holistic treatment approaches, the emergence of digital health solutions, the high prevalence of mental health disorders, and the improving macroeconomic conditions. These factors are driving the demand for pharmaceutical products and therapies, creating opportunities for growth in the market.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.